Cargando…

Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment

INTRODUCTION: The metabolic deregulation associated with diabetes mellitus (DM) causes secondary pathophysiologic changes in multiple organ systems. Endothelial injury is induced by oxidative stress (OS) and inflammation. We have previously shown that DM type 2 patients are exposed to increased OS a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farah, Raymond, Shurtz-Swirski, Revital, Lapin, Olga
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2441608/ https://www.ncbi.nlm.nih.gov/pubmed/18570678 http://dx.doi.org/10.1186/1475-2840-7-20

Ejemplares similares

Lercanidipine Effect on Polymorphonuclear Leukocyte-Related Inflammation and Insulin Resistance in Essential Hypertension Patients
por: Farah, Raymond, et al.
Publicado: (2012)

Patterns and predictors of antihyperglycemic intensification at hospital discharge for type 2 diabetic patients not on home insulin
por: Abusamaan, Mohammed S., et al.
Publicado: (2020)

Predictors and Impact of Intensification of Antihyperglycemic Therapy in Type 2 Diabetes: Translating Research into Action for Diabetes (TRIAD)
por: McEwen, Laura N., et al.
Publicado: (2009)

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes
por: Paul, Sanjoy K, et al.
Publicado: (2015)

Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes
por: Odegaard, Andrew O., et al.
Publicado: (2016)

Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease
por: Luo, Jing, et al.
Publicado: (2023)

Prevalence of Diabetes Medication Intensifications in Older Adults Discharged From US Veterans Health Administration Hospitals
por: Anderson, Timothy S., et al.
Publicado: (2020)

Intensification of Diabetes Medications at Hospital Discharge and Clinical Outcomes in Older Adults in the Veterans Administration Health System
por: Anderson, Timothy S., et al.
Publicado: (2021)

Preserved endothelium-dependent dilatation of the coronary microvasculature at the early phase of diabetes mellitus despite the increased oxidative stress and depressed cardiac mechanical function ex vivo
por: Mourmoura, Evangelia, et al.
Publicado: (2013)

Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients
por: Movahed, Ali, et al.
Publicado: (2013)

Antihyperglycemic action of rhodiola-aqeous extract in type1-like diabetic rats
por: Niu, Chiang-Shan, et al.
Publicado: (2014)

Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes
por: Tunceli, Kaan, et al.
Publicado: (2015)

Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus
por: Zhu, Wei, et al.
Publicado: (2019)

Role of inflammation and oxidative stress in the etiology of primary ovarian insufficiency
por: Ağaçayak, Elif, et al.
Publicado: (2016)

Cardiac lipid content is unresponsive to a physical activity training intervention in type 2 diabetic patients, despite improved ejection fraction
por: Schrauwen-Hinderling, Vera B, et al.
Publicado: (2011)

Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction
por: Lamberts, Regis R, et al.
Publicado: (2014)

Impact of Hypoglycemia Associated With Antihyperglycemic Medications on Vascular Risks in Veterans With Type 2 Diabetes
por: Zhao, Yingnan, et al.
Publicado: (2012)

Antihyperglycemic treatment in patients with type 2 diabetes in Italy: the impact of age and kidney function
por: Gentile, Sandro, et al.
Publicado: (2017)

Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes
por: Guzauskas, Gregory F, et al.
Publicado: (2021)

Myocardial dysfunction in patients with type 2 diabetes mellitus: role of endothelial progenitor cells and oxidative stress
por: Zhao, Chun Ting, et al.
Publicado: (2012)

Extract of Bauhinia vahlii Shows Antihyperglycemic Activity, Reverses Oxidative Stress, and Protects against Liver Damage in Streptozotocin-induced Diabetic Rats
por: Elbanna, Ahmed H., et al.
Publicado: (2017)

Antihyperglycemic and hepatoprotective effects of Salvia tebesana Bunge in diabetic rats
por: Aramjoo, Hamed, et al.
Publicado: (2022)

Transitions of Care for People with Type 2 Diabetes: Utilization of Antihyperglycemic Agents Pre- and Post-Hospitalization
por: Montejano, Leslie, et al.
Publicado: (2015)

A Survey of Patient Preferences for Oral Antihyperglycemic Therapy in Patients with Type 2 Diabetes Mellitus
por: Hauber, A. Brett, et al.
Publicado: (2015)

Canagliflozin: Efficacy and Safety in Combination with Metformin Alone or with Other Antihyperglycemic Agents in Type 2 Diabetes
por: Qiu, Rong, et al.
Publicado: (2016)

Basal Insulin Intensification in Patients with Type 2 Diabetes: A Review
por: Meece, Jerry
Publicado: (2018)

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART
por: Rusconi, S, et al.
Publicado: (2010)

Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes
por: Currie, Craig J., et al.
Publicado: (2013)

Rapid Gene Family Evolution of a Nematode Sperm Protein Despite Sequence Hyper-conservation
por: Kasimatis, Katja R., et al.
Publicado: (2017)

Antihyperglycemic activity of Eclipta alba leaf on alloxan-induced diabetic rats.
por: Ananthi, J., et al.
Publicado: (2003)

Antihyperglycemic Effect of Ganoderma Lucidum Polysaccharides on Streptozotocin-Induced Diabetic Mice
por: Li, Fenglin, et al.
Publicado: (2011)

Antihyperglycemic Effect of Ginkgo biloba Extract in Streptozotocin-Induced Diabetes in Rats
por: Cheng, Daye, et al.
Publicado: (2013)

Antihyperglycemic Activity of Houttuynia cordata Thunb. in Streptozotocin-Induced Diabetic Rats
por: Kumar, Manish, et al.
Publicado: (2014)

Association of Antihyperglycemic Therapy with Risk of Atrial Fibrillation and Stroke in Diabetic Patients
por: Lăcătușu, Cristina-Mihaela, et al.
Publicado: (2019)

Antihyperglycemic and Lipid Profile Effects of Salvia amarissima Ortega on Streptozocin-Induced Type 2 Diabetic Mice
por: Solares-Pascasio, Jesus Ivan, et al.
Publicado: (2021)

Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus
por: Nargesi, Arash A., et al.
Publicado: (2021)

A RESPONSE TO: “COST-EFFECTIVENESS OF ORAL SEMAGLUTIDE ADDED TO CURRENT ANTIHYPERGLYCEMIC TREATMENT FOR TYPE 2 DIABETES”
por: Kohli-Lynch, Ciaran N, et al.
Publicado: (2021)

Heredity of type 2 diabetes confers increased susceptibility to oxidative stress and inflammation
por: Baig, Sonia, et al.
Publicado: (2020)

Intensification to injectable therapy in type 2 diabetes: mixed methods study (protocol)
por: de Lusignan, Simon, et al.
Publicado: (2019)

Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation
por: Gajos, Grzegorz, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p640oqi1anui5h2nk170oka655